CONTRIBUTORS

Autonomic Disorders p. 6-9 February 2020, Vol.26, No.1 doi: 10.1212/01.CON.0000654528.30809.9a
CONTRIBUTORS
BROWSE ARTICLES

Eduardo E. Benarroch, MD, FAAN Guest Editor

Professor of Neurology; Consultant, Department of Neurology, Mayo Clinic, Rochester, Minnesota

Relationship Disclosure: Dr Benarroch serves as a section editor for Neurology, has received personal compensation for speaking engagements from Lundbeck, and receives publishing royalties from Oxford University Press.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Benarroch reports no disclosure.

Marta Campagnolo, MD

Neurologist, Department of Neurosciences, University of Padova, Padova, Italy

Relationship Disclosure: Dr Campagnolo reports no disclosure.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Campagnolo reports no disclosure.

William P. Cheshire Jr, MD, FAAN

Professor of Neurology, Mayo Clinic, Jacksonville, Florida

Relationship Disclosure: Dr Cheshire serves as an associate editor for Clinical Autonomic Research and on the editorial boards of Autonomic Neuroscience: Basic & Clinical and Parkinsonism & Related Disorders. Dr Cheshire has received personal compensation for travel from Biohaven and for speaking engagements for Trinity Graduate School.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Cheshire discusses the unlabeled/investigational use of alizarin red and starch iodine for the visualization of sudomotor responses and the unlabeled/investigational use of amitriptyline, clonidine, endoscopic transthoracic sympathotomy, gabapentin, glycopyrrolate, morphine, and steroids for the treatment of sweating disorders.

Elizabeth A. Coon, MD

Assistant Professor of Neurology, Mayo Clinic, Rochester, Minnesota

Relationship Disclosure: Dr Coon reports no disclosure.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Coon discusses the unlabeled/investigational use of pyridostigmine for orthostatic hypotension and clonazepam and melatonin for dream enactment behavior and the unlabeled/investigational use of amitriptyline, clonidine, endoscopic transthoracic sympathotomy, gabapentin, glycopyrrolate, morphine, and steroids for the treatment of sweating disorders.

Jeremy K. Cutsforth-Gregory, MD

Assistant Professor of Neurology, Mayo Clinic, Rochester, Minnesota

Relationship Disclosure: Dr Cutsforth-Gregory receives publishing royalties from Mayo Clinic Scientific Press and Oxford University Press.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Cutsforth-Gregory discusses the unlabeled/investigational use of droxidopa, fludrocortisone, ivabradine, midodrine, propranolol, and pyridostigmine.

Roy Freeman, MBChB

Professor of Neurology, Harvard Medical School; Director, Center for Autonomic and Peripheral Nerve Disorders, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Relationship Disclosure: Dr Freeman has received personal compensation and/or stock options for serving on scientific advisory boards of Abide Therapeutics; Applied Therapeutics, Inc; Aptinyx, Inc; Astellas Pharma; Biogen; Biohaven Pharmaceuticals; Chromocell; Cutaneous Neurodiagnostics, LLC; GW Pharmaceuticals, plc; Ironwood Pharmaceuticals; Lundbeck; Mundipharma; NeuroBo Pharmaceuticals; Novartis; Pfizer, Inc; Regenacy Pharmaceuticals; Spinifex Pharmaceuticals; Theravance Biopharma; Toray Medical Co, Ltd; and Vertex Pharmaceuticals. Dr Freeman has received personal compensation for serving as editor-in-chief of Autonomic Neuroscience: Basic & Clinical.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Freeman reports no disclosure.

Christopher H. Gibbons, MD, MMSc, FAAN

Associate Professor of Neurology, Harvard Medical School, Boston, Massachusetts

Relationship Disclosure: Dr Gibbons has received personal compensation for serving as a scientific advisor for Theravance Biopharma and Lundbeck and as an associate editor for Autonomic Neuroscience: Basic & Clinical, research/grant support from Grifols, and publishing royalties from UpToDate, Inc. Dr Gibbons has held stock/stock options in Cutaneous Neurodiagnostics, LLC, and has given expert medical testimony.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Gibbons reports no disclosure.

Horacio Kaufmann, MD

Professor of Neurology, Medicine, and Pediatrics; Director, Dysautonomia Center, New York University School of Medicine, New York, New York

Relationship Disclosure: Dr Kaufmann serves as editor-in-chief of Clinical Autonomic Research and as a consultant for and on the scientific advisory boards of Biogen, Biohaven Pharmaceuticals, Lundbeck, and Pfizer Inc. Dr Kaufmann receives research/grant support from the Familial Dysautonomia Foundation, Inc; the Michael J. Fox Foundation for Parkinson's Research; the Multiple System Atrophy Coalition; the National Institutes of Health (R01HL103988, U54NS065736); Theravance Biopharma; and the US Food and Drug Administration (FDR3731-01) and publishing royalties from UpToDate, Inc. Dr Kaufmann has served as an expert witness for the Department of Justice regarding the alleged relationship between human papilloma virus vaccination and autonomic disorders.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Kaufmann discusses the unlabeled/investigational use of acarbose, ampreloxetine, atomoxetine, erythropoietin, fludrocortisone, octreotide, and pyridostigmine for the treatment of orthostatic hypotension.

Jee Young Kim, MD

Clinical Associate Professor, Myongji Hospital/Hanyang University College of Medicine/Goyang-si, Gyeonggi-do, Republic of Korea

Relationship Disclosure: Dr Kim reports no disclosure.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Kim reports no disclosure.

Jose-Alberto Palma, MD, PhD

Associate Professor of Neurology, New York University School of Medicine, New York, New York

Relationship Disclosure: Dr Palma serves as managing editor for Clinical Autonomic Research and as a consultant for Biogen, Dr Reddy’s Laboratories Ltd, Lundbeck, and PTC Therapeutics. Dr Palma receives research/grant support from the Familial Dysautonomia Foundation, Inc; the Michael J. Fox Foundation for Parkinson’s Research; the Multiple System Atrophy Coalition; and the National Institute of Neurological Disorders and Stroke (R01NS107596, U54NS065736).

Unlabeled Use of Products/Investigational Use Disclosure: Dr Palma discusses the unlabeled/investigational use of acarbose, ampreloxetine, atomoxetine, erythropoietin, fludrocortisone, octreotide, and pyridostigmine for the treatment of orthostatic hypotension.

Jalesh N. Panicker, MD, DM, FRCP

Consultant Neurologist and Clinical Lead Reader in Uro-Neurology and Clinical Neurology, the National Hospital for Neurology and Neurosurgery, University College London Queen Square Institute of Neurology, London, United Kingdom

Relationship Disclosure: Dr Panicker has received personal compensation for speaking engagements from Astellas Pharma Inc and Wellspect HealthCare and receives research/grant support from the United Kingdom’s Department of Health National Institute of Health Research Biomedical Research Centres funding scheme and publishing royalties from Cambridge University Press.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Panicker reports no disclosure.

Alejandro A. Rabinstein, MD, FAAN

Professor of Neurology, Mayo Clinic, Rochester, Minnesota

Relationship Disclosure: Dr Rabinstein serves as an associate editor of Neurocritical Care and on the editorial board of Continuum and receives publishing royalties from Elsevier and Oxford University Press.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Rabinstein reports no disclosure.

Ryuji Sakakibara, MD, PhD, FAAN

Professor of Neurology and Internal Medicine, Sakura Medical Center, Toho University, Sakura, Japan

Relationship Disclosure: Dr Sakakibara reports no disclosure.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Sakakibara reports no disclosure.

Wolfgang Singer, MD

Consultant; Associate Professor of Neurology, Mayo Clinic, Rochester, Minnesota

Relationship Disclosure: Dr Singer serves on the editorial board of Autonomic Neuroscience: Basic & Clinical, as an associate editor for Clinical Autonomic Research, as a consultant for Biohaven Pharmaceuticals, and on an advisory board for Lundbeck. Dr Singer receives research/grant support from Dysautonomia International, the National Institutes of Health (R01 NS092625, U54 NS65736), and the US Food and Drug Administration (R01 FD4789).

Unlabeled Use of Products/Investigational Use Disclosure: Dr Singer discusses the unlabeled/investigational use of pyridostigmine for orthostatic hypotension and clonazepam and melatonin for dream enactment behavior.

Steven Vernino, MD, PhD, FAAS, FAAN

Distinguished Teaching Professor; Dr. Bob and Jean Smith Foundation Distinguished Chair in Neuromuscular Disease Research, University of Texas Southwestern Medical Center, Dallas, Texas

Relationship Disclosure: Dr Vernino serves on the board of directors of the American Autonomic Society; the scientific advisory boards of Argenx, Dysautonomia International, and the Multiple System Atrophy Coalition; and the editorial boards of Autonomic Neuroscience: Basic & Clinical and Clinical Autonomic Research. Dr Vernino receives research/grant support from Dysautonomia International; Genentech, Inc; Grifols, SA; the Rex Griswold Foundation; and Theravance and licensing fees to support his laboratory from Quest Diagnostics Inc.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Vernino discusses the unlabeled/investigational use of immunomodulatory treatments for autoimmune disorders.

Ningshan Wang, MD, PhD

Instructor of Neurology, Harvard Medical School, Boston, Massachusetts

Relationship Disclosure: Dr Wang reports no disclosure.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Wang reports no disclosure.

Self-Assessment and CME Test Writers

Allison L. Weathers, MD, FAAN

Associate Chief Medical Information Officer, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio

Relationship Disclosure: Dr Weathers serves on the editorial board of Continuum and as chair of the adult neurosciences specialty steering board for Epic.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Weathers reports no disclosure.

Allyson R. Zazulia, MD

Professor of Neurology and Radiology, Associate Dean for Continuing Medical Education, Washington University, St. Louis, Missouri

Relationship Disclosure: Dr Zazulia reports no disclosure.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Zazulia reports no disclosure.

© 2020 American Academy of Neurology.